Hamza Hashmi
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 63
- Multiple Myeloma Research and Treatments 50
- Hematopoietic Stem Cell Transplantation 6
- Chronic Myeloid Leukemia Treatments 5
- Oncology 55
- CAR-T cell therapy research 40
- Co-authors
- James A. Davis (38 shared papers)Al‐Ola Abdallah (33 shared papers)Nausheen Ahmed (33 shared papers)Faiz Anwer (21 shared papers)Joseph P. McGuirk (17 shared papers)Jack Khouri (17 shared papers)Danai Dima (18 shared papers)Leyla Shune (14 shared papers)
- Journals
- Blood (21 papers)Transplantation and Cellular Therapy (19 papers)Journal of Clinical Oncology (5 papers)European Journal Of Haematology (3 papers)Biology of Blood and Marrow Transplantation (3 papers)
- Partner nations
- United StatesPakistanIndia
In The Last Decade
Hamza Hashmi
92 papers receiving 528 citations
Peers
Comparison fields: 5 of 56
- Hematology 212
- Oncology 285
- Genetics 40
- Immunology 68
- Molecular Biology 158
Countries citing papers authored by Hamza Hashmi
This map shows the geographic impact of Hamza Hashmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamza Hashmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamza Hashmi more than expected).
Fields of papers citing papers by Hamza Hashmi
This network shows the impact of papers produced by Hamza Hashmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamza Hashmi. The network helps show where Hamza Hashmi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamza Hashmi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 42 | |
| 2 | 2020 | 37 | |
| 3 | 2016 | 35 | |
| 4 | 2023 | 30 | |
| 5 | 2022 | 28 | |
| 6 | 2023 | 23 | |
| 7 | 2024 | 20 | |
| 8 | 2023 | 17 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 13 | |
| 11 | 2024 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2021 | 10 | |
| 15 | 2023 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2018 | 9 | |
| 18 | 2022 | 7 | |
| 19 | 2022 | 7 | |
| 20 | 2019 | 7 |
About Hamza Hashmi
Hamza Hashmi is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 105 papers that have together received 532 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (50 papers), CAR-T cell therapy research (40 papers), Protein Degradation and Inhibitors (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Hematology (212 citations), Oncology (285 citations), Genetics (40 citations), Immunology (68 citations) and Molecular Biology (158 citations). Hamza Hashmi has collaborated with scholars based in United States, Pakistan and India. Frequent co-authors include James A. Davis, Al‐Ola Abdallah, Nausheen Ahmed, Faiz Anwer, Joseph P. McGuirk, Jack Khouri, Danai Dima, Leyla Shune, Shahzad Raza and Zahra Mahmoudjafari. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Journal of Clinical Oncology, European Journal Of Haematology and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.